StimLabs, LLC
StimLabs is a private regenerative medicine company that develops and sells FDA-cleared placental tissue and collagen scaffold products for wound care. It serves physicians, podiatrists, hospitals, and clinical facilities treating chronic wounds, diabetic foot ulcers, surgical wounds, and burns.
- Company typePrivate
- Founded2016
- HeadquartersRoswell, United States
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What StimLabs, LLC does
StimLabs, LLC is a private regenerative medicine company founded in 2015 and headquartered in Roswell, Georgia, that develops and commercializes placental tissue-based and collagen scaffold products for wound care applications. The company maintains a portfolio of 10 products organized into office-based solutions (Allacor P, Derma-Gide, Relese, Revita, Cogenex) and hospital-based solutions (Architect Fx, Corplex P, Vialize, Enverse, Revita Burn Clear), with five products holding FDA 510(k) clearance. Core technology centers on proprietary placental tissue processing methods, including dehydrated human umbilical cord particulate (dHUCP) and dehydrated chorionic human placental membrane (dCHPM) technologies, used for chronic wound management, diabetic foot ulcers, surgical wound dehiscence, and burn care. Most recently, StimLabs expanded into collagen scaffold particulates through the FDA-cleared DermaForm device, co-developed with Swiss regenerative medicine leader Geistlich.
StimLabs operates a B2B medical device sales model targeting healthcare providers and physicians (primary segment) and hospitals and clinical facilities (secondary segment), with use cases spanning wound care, chronic wound management, acute surgical wounds, diabetic foot ulcers, and burn care. Distribution is conducted through an authenticated provider portal (portal.stimlabs.com) with online payment capabilities, supported by content marketing through clinical case studies, physician and patient testimonials, and regulatory announcements. The company holds exclusive distribution rights for Geistlich's Derma-Gide and Harbor MedTech's Architect brands, and its own product and corporate trademarks (13+ registered, including StimLabs, Revita, Cogenex, Enverse, Vialize, Relese, Clearify, Corplex P, Theracor, Allacor P, and DermaForm) reinforce brand distinctiveness. Pricing is not publicly disclosed and follows a quote-based B2B medical device convention.
The company is led by founder and CEO John Daniel. It operates as an LLC domiciled in Georgia with no disclosed parent company, external private equity backing, or venture capital ownership despite an Investors page on the corporate website. Revenue is not publicly disclosed; the company sits in the 101-250 employee range, consistent with a mid-stage commercial regenerative medicine business competing in a soft tissue allograft market projected to reach $6.97B by 2030 at a 7.4% CAGR.
StimLabs, LLC firmographics
Firmographics- Name
- StimLabs, LLC
- Legal name
- Stimlabs LLC
- Website
- https://stimlabs.net
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- StimLabs is a private regenerative medicine company that develops and sells FDA-cleared placental tissue and collagen scaffold products for wound care. It serves physicians, podiatrists, hospitals, and clinical facilities treating chronic wounds, diabetic foot ulcers, surgical wounds, and burns.
- Ownership category
- akta.pro rank
StimLabs, LLC industry classification
Industry- Product category
- Regenerative Medicine — Wound Care Devices
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts) (HLAHALAE)
- akta.pro secondary industry
- Wound Healing & Skin Regeneration (advanced dressings, skin substitutes) (HLAAAGAG)
Keywords
Where StimLabs, LLC is headquartered
LocationHeadquarters
- HQ city
- Roswell
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
StimLabs, LLC business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
Revenue model
- Medical Device Sales: StimLabs generates revenue through the sale of FDA 510(k) cleared regenerative medicine products including wound care devices, placental tissue products, and collagen scaffold devices sold to healthcare providers and hospitals.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels3 records
StimLabs, LLC product offering
Product offeringCore offering
StimLabs develops, manufactures, and distributes FDA 510(k)-cleared regenerative medicine products derived from placental tissue for wound care applications. The portfolio includes office-based solutions (Allacor P, Derma-Gide, Relese, Revita, Cogenex) for outpatient wound management and hospital-based solutions (Architect Fx, Corplex P, Vialize, Enverse, Revita Burn Clear) for acute and surgical wound care, sold to healthcare providers and clinical facilities.
Product overview
StimLabs offers an innovative and comprehensive product portfolio of placental tissue-based regenerative medicine products designed for wound care applications. The portfolio is organized into two categories: Office-Based Solutions (Allacor P, Derma-Gide, Relese, Revita, Cogenex) for outpatient and clinic settings, and Hospital-Based Solutions (Architect Fx, Corplex P, Vialize, Enverse, Revita Burn Clear) for acute care environments. Several products hold FDA 510(k) clearance. The company recently expanded its portfolio with DermaForm, a collagen scaffold particulate wound care device developed in collaboration with Swiss partner Geistlich. All products leverage placental tissue technology for regenerative wound healing.
Differentiator
Problem solved
Functional benefit
Products and services
- Allacor P (510(k)) Office-based placental tissue product for regenerative wound care applications, FDA 510(k) cleared and intended for physicians and outpatient clinics.
- Derma-Gide (510(k)) Office-based wound care device derived from placental tissue, designed for soft tissue reconstruction. FDA 510(k) cleared; distributed by StimLabs and trademark of Geistlich Pharma AG.
- Relese Office-based placental tissue product for regenerative medicine applications, intended for outpatient and clinic settings.
- Revita Office-based placental tissue product for regenerative wound care applications, intended for outpatient and clinic use.
- Cogenex Office-based placental tissue product for regenerative medicine applications, intended for outpatient and clinic settings.
- Architect Fx (510(k)) Hospital-based placental tissue product for surgical and wound care applications, FDA 510(k) cleared and intended for use in acute care environments.
- Corplex P (510(k)) Hospital-based placental tissue product designed for complex wound management including diabetic foot ulcers and surgical wound dehiscence; uses dHUCP technology and is FDA 510(k) cleared.
- Vialize Hospital-based placental tissue product for regenerative medicine applications, intended for use in acute care and surgical environments.
- Enverse Hospital-based placental tissue product for regenerative wound care, intended for acute care settings.
- Revita Burn Clear Specialized hospital-based placental tissue product designed for burn wound management in acute care environments.
- DermaForm Collagen scaffold particulate wound care device designed for chronic and acute wounds. FDA 510(k) cleared; developed through collaboration with Geistlich Pharma AG.
Quantifiable outcome
- Products demonstrated effective wound healing in clinical case studies including diabetic foot ulcers and surgical wound dehiscence
Companies that use StimLabs, LLC
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles2 records
StimLabs, LLC technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
StimLabs, LLC partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- GeistlichcoreStimLabs collaborated with Geistlich, a Swiss family-owned company and global leader in regenerative medicine, to obtain FDA 510(k) clearance for DermaForm, a collagen scaffold particulate wound care device. Geistlich is a co-development and technology partner providing collagen scaffold expertise for the product. The partnership represents a significant portfolio milestone for StimLabs in wound care solutions.
Scale indicators2 records
Recent moves6 records
Expansion highlights5 records
StimLabs, LLC competitors and assessment
Company assessmentDirect peers
- MiMedx Group: MiMedx is a direct competitor in placental tissue-based regenerative medicine, offering amniotic membrane products (e.g., EpiFix, AmnioFix) for wound care and surgical applications. It is the most direct peer given its shared focus on dehydrated human amnion/chorion membrane technologies targeting the same clinical indications.
- Organogenesis: Organogenesis is a direct peer in advanced wound care biologics, offering Apligraf and Dermagraft (living cell-based skin substitutes) for chronic wounds. Competes in the same physician office and hospital channels with overlapping indications such as diabetic foot ulcers and venous leg ulcers.
- Amniox Medical (TissueTech): Amniox Medical (part of TissueTech) is a direct peer specializing in cryopreserved amniotic membrane and umbilical cord tissue products (e.g., NEOX, CLARIX) for wound healing and surgical applications. Highly comparable given the shared use of human placental tissue for regenerative wound care.
- AlloSource: AlloSource is a direct peer as a non-profit allograft provider offering placental tissue and dermal products for wound care and surgical applications. Comparable in tissue processing technology and customer base of hospitals and surgeons.
Broad incumbents
- Stryker: Stryker is a broad medical device incumbent that competes in surgical wound care, biologics, and orthopedics through its instruments and surgical solutions segments. Overlaps with StimLabs' hospital-based wound care products sold into surgical settings.
- Integra LifeSciences: Integra LifeSciences is a broad incumbent in regenerative medicine and wound care, offering dermal regeneration templates (Integra Dermal Regeneration Template), amniotic products, and surgical devices. Overlaps with StimLabs in advanced wound care and tissue regeneration but operates across a much broader portfolio.
- Convatec: Convatec is a broad incumbent in advanced wound care and ostomy management, offering hydrocolloid and antimicrobial dressings plus skin barrier products. Relevant as a competitor for hospital and outpatient wound care budgets, though its portfolio emphasizes traditional dressings rather than biologic skin substitutes.
- Coloplast: Coloplast is a broad incumbent in wound and skin care, with a Biatain product line targeting chronic wounds. Comparable in addressing diabetic foot ulcers and chronic wound management, but operates across ostomy, continence, and wound care rather than specializing in placental tissue biologics.
- Smith+Nephew: Smith+Nephew is a major global wound care incumbent offering advanced wound dressings, negative pressure wound therapy, and skin substitutes. Competes in the same hospital and office-based channels but operates as a diversified medical device company rather than a placental tissue specialist.
Emerging players
- Vericel: Vericel is an emerging player in cellular therapies and specialty biologics for wound care and surgical repair, including MACI for cartilage repair. Comparable as a smaller, specialized regenerative medicine company competing in adjacent indications within hospital channels.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
StimLabs, LLC social profiles
Digital presenceStimLabs, LLC financial estimates
Financial estimateRevenue estimate
Valuation estimate
StimLabs, LLC leadership team
Management profileNumber of profiles
Profiles1 record
StimLabs, LLC funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
StimLabs, LLC M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about StimLabs, LLC
What does StimLabs, LLC do?
StimLabs develops, manufactures, and distributes FDA 510(k)-cleared regenerative medicine products derived from placental tissue for wound care applications. The portfolio includes office-based solutions (Allacor P, Derma-Gide, Relese, Revita, Cogenex) for outpatient wound management and hospital-based solutions (Architect Fx, Corplex P, Vialize, Enverse, Revita Burn Clear) for acute and surgical wound care, sold to healthcare providers and clinical facilities.
Is StimLabs, LLC a public or private company?
StimLabs, LLC is a private company. It is classified as unknown and is currently operating.
When was StimLabs, LLC founded?
StimLabs, LLC was founded in 2016. It employs 101 to 250 people.
Where is StimLabs, LLC based?
StimLabs, LLC is headquartered in Roswell, United States, in the North America region.
How does StimLabs, LLC make money?
One revenue line is on record: medical Device Sales.
Who are StimLabs, LLC's main competitors?
Direct peers on record are MiMedx Group, Organogenesis, Amniox Medical (TissueTech) and AlloSource. Broad incumbents are Stryker, Integra LifeSciences, Convatec, Coloplast and Smith+Nephew. Vericel is listed as an emerging player.
Does StimLabs, LLC have an API?
No public API is recorded for StimLabs, LLC.
What industry is StimLabs, LLC in?
StimLabs, LLC's product category is Regenerative Medicine — Wound Care Devices. Its primary akta.pro industry code is HLAHALAE, Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts), with a secondary code of HLAAAGAG, Wound Healing & Skin Regeneration (advanced dressings, skin substitutes). Its NAICS code is 339113 and its SIC code is 3841.